KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $671,000 | -30.1% | 50,000 | -50.0% | 1.32% | +58.6% |
Q4 2017 | $960,000 | -12.6% | 100,000 | 0.0% | 0.83% | -15.7% |
Q3 2017 | $1,098,000 | +21.3% | 100,000 | 0.0% | 0.98% | +18.8% |
Q2 2017 | $905,000 | +104.8% | 100,000 | +102.0% | 0.83% | +142.4% |
Q1 2016 | $442,000 | -44.4% | 49,500 | -17.5% | 0.34% | -34.9% |
Q4 2015 | $795,000 | +412.9% | 60,000 | +306.8% | 0.52% | +510.5% |
Q3 2015 | $155,000 | -66.2% | 14,750 | -1.7% | 0.09% | -77.7% |
Q1 2015 | $459,000 | – | 15,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |